| pubmed-article:11251945 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11251945 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11251945 | lifeskim:mentions | umls-concept:C1168401 | lld:lifeskim |
| pubmed-article:11251945 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:11251945 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:11251945 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:11251945 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:11251945 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:11251945 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11251945 | pubmed:dateCreated | 2001-3-19 | lld:pubmed |
| pubmed-article:11251945 | pubmed:abstractText | After standard therapy for advanced head and neck carcinoma, 5-year survival rate is less than 50%. Our purpose was to develop a new treatment for advanced head and neck carcinoma by using preoperative chemotherapy. Long term efficacy and toxicity of induction paclitaxel and carboplatin is reported here. | lld:pubmed |
| pubmed-article:11251945 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11251945 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11251945 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11251945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11251945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11251945 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11251945 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11251945 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:11251945 | pubmed:author | pubmed-author:EBYT MTM | lld:pubmed |
| pubmed-article:11251945 | pubmed:author | pubmed-author:HarrisonB RBR | lld:pubmed |
| pubmed-article:11251945 | pubmed:author | pubmed-author:BondE DED | lld:pubmed |
| pubmed-article:11251945 | pubmed:author | pubmed-author:DunphyF RFR | lld:pubmed |
| pubmed-article:11251945 | pubmed:author | pubmed-author:StackB CBCJr | lld:pubmed |
| pubmed-article:11251945 | pubmed:author | pubmed-author:NeedlesBB | lld:pubmed |
| pubmed-article:11251945 | pubmed:author | pubmed-author:TrinkausK MKM | lld:pubmed |
| pubmed-article:11251945 | pubmed:author | pubmed-author:DunleavyT LTL | lld:pubmed |
| pubmed-article:11251945 | pubmed:copyrightInfo | Copyright 2001 American Cancer Society. | lld:pubmed |
| pubmed-article:11251945 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11251945 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11251945 | pubmed:volume | 91 | lld:pubmed |
| pubmed-article:11251945 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11251945 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11251945 | pubmed:pagination | 940-8 | lld:pubmed |
| pubmed-article:11251945 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:meshHeading | pubmed-meshheading:11251945... | lld:pubmed |
| pubmed-article:11251945 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11251945 | pubmed:articleTitle | Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 an 1999. | lld:pubmed |
| pubmed-article:11251945 | pubmed:affiliation | Department of Internal Medicine, Division of Hematology and Oncology, Saint Louis University Health Sciences Center, St. Louis, Missouri 63110-0250, USA. | lld:pubmed |
| pubmed-article:11251945 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11251945 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11251945 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
